Kevin Charles Gorman Neurocrine Biosciences Inc (NBIX) insider trading activity

Kevin Charles Gorman is Director of NEUROCRINE BIOSCIENCES INC. Currently has a direct ownership of 524,209 shares of NBIX, which is worth approximately $59.9 Million. The most recent transaction as insider was on Feb 05, 2021, when has been sold 2,422 shares (Common Stock) at a price of $114.16 per share, resulting in proceeds of $276,496. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 524K

1.87% 3M change

1.87% 12M change

Total Value Held $59.9 Million

KEVIN CHARLES GORMAN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 05 2021	SELL Open market or private sale	$276,496 $114.16 p/Share	2,422 Reduced 0.54%	443,249 Common Stock
Jan 08 2021	SELL Open market or private sale	$33,975,315 $110.22 p/Share	308,250 Reduced 41.14%	441,071 Common Stock
Jan 08 2021	BUY Exercise of conversion of derivative security	$2,669,445 $8.66 p/Share	308,250 Added 33.72%	605,872 Common Stock
Nov 12 2020	SELL Open market or private sale	$307,744 $90.78 p/Share	3,390 Reduced 0.76%	441,071 Common Stock

Also insider at

XNCR

Xencor Inc Healthcare

Director

KCG